Anxiety (GAD-7)

Anxiety (GAD-7) is a mood-related measurement presented for clear, accessible reference. It uses points to express the measurement, providing a concise way to represent anxiety-related status in a reference format.

Take this measurement weekly and record the result in points. Use the same measurement method each time and keep the weekly schedule consistent so readings can be compared from one week to the next. Note the date of each reading to make gaps in the schedule clear.

Interpret the direction consistently: lower scores are better. Compare successive weekly readings rather than relying on a single result, and use the healthy range shown beside the measurement as a reference.

For Anxiety (GAD-7), lower scores are more favorable because the measure is designed to reflect fewer reported anxiety symptoms. The healthy range can serve as a personal orientation point, not as a verdict or a definition of how someone is doing overall. A value outside that range does not, by itself, explain the reason for the result or determine what action is appropriate.

Because this measure is intended for weekly use, the pattern across several readings is more informative than any single score. Look for whether scores are generally moving lower, remaining similar, or moving higher over time rather than placing too much weight on one result. Comparisons are most meaningful when the questionnaire is completed consistently; changes in timing, setting, or technique can make one reading less directly comparable with another. Use the same approach from week to week where possible, and treat the trend as context for reflection rather than a standalone conclusion.

No intervention in the evidence set measured Anxiety (GAD-7) directly. The interventions described here instead target effects that this marker tracks, though trials did not measure it directly. Because lower Anxiety (GAD-7) scores are better, the relevant direction is improvement through reduced anxiety, rumination, or better emotional regulation.

For related anxiety reduction, Yoga, Tai Chi, Meditation, Lavender Extract, Omega-3, and TENS / EMS Therapy moved anxiety-related outcomes in a favorable direction. For rumination reduction, Meditation, Choline (Bitartrate), Gratitude Journal, 5-HTP, Ashwagandha, and Bacopa Monnieri were described as favorable, but the level and type of support varies substantially. Emotional-regulation outcomes likewise favored Meditation, Yoga, Tai Chi, Box Breathing, Selenium, and Gratitude Journal.

The most informative support comes from human randomized trials and meta-analyses involving Meditation, Yoga, Tai Chi, Lavender Extract, Omega-3, Box Breathing, Selenium, and some emotional-regulation outcomes. Other entries rely on clinical evidence, theoretical or pharmacology references, or anecdotal reports, so they provide weaker grounds for anticipating movement in this marker. Studies included mixed, healthy, and clinical-condition populations, meaning the findings may not apply equally across people.

Where timing was reported, related-effect interventions were generally evaluated over 3-26 weeks; one Selenium study continued up to 24 months. These time frames describe the related outcomes studied, not a confirmed time for changing Anxiety (GAD-7).